Skip to content

Comparison of ultrasound-guided cervical vagus nerve block versus thoracoscopic thoracic vagus nerve block for suppression of the cough reflex in non-intubated video-assisted thoracoscopic pulmonary surgery: a prospective, randomized, controlled, non-inferiority trial

Comparison of ultrasound-guided cervical vagus nerve block and thoracoscopic thoracic vagus nerve block in non-intubated video-assisted thoracoscopic pulmonary surgery: a prospective, randomized, controlled, non-inferiority trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128554
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative cough reflex

Interventions

Thoracic vagus nerve block group:Injection of 5 mL of 2% lidocaine at the thoracic vagus nerve under thoracoscopic guidance.
Cervical vagus nerve block group:Injection of 5 mL of 2% lidocaine at the cervical vagus nerve under ultrasound guidance.

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18–65 years at the time of enrollment; 2. Body mass index (BMI) < 26 kg/m²; 3. Pulmonary tumor, with a maximum tumor diameter < 6 cm, and no evidence of endobronchial involvement or distant metastasis; 4. American Society of Anesthesiologists (ASA) Physical Status classification I–II; 5. Written informed consent obtained prior to any study-related procedures.

Exclusion criteria

Exclusion criteria: 1. History of prior pulmonary resection, or presence of cardiac insufficiency (e.g., left ventricular ejection fraction [LVEF] < 40%); 2. Recent use of anticoagulants (e.g., within the past 3 months) or known coagulation disorders/coagulopathy; 3. Known allergy or hypersensitivity to local anesthetics, opioids, or any other study-related medications used in the procedures; 4. Severe pleural adhesions suggested on preoperative imaging; 5. Any other condition deemed by the investigator to render the participant unsuitable for enrollment (e.g., pregnancy, lactation, psychiatric disorders, etc.).

Design outcomes

Primary

MeasureTime frame
Incidence of intraoperative cough (grade 2–4);Severity of intraoperative cough (grade 1–4);

Secondary

MeasureTime frame
Surgical duration;Postoperative complications (dyspnea, sore throat, nausea/vomiting, incision pain, fever, pulmonary infection);Intraoperative arterial blood gas (PaCO2, pH);Incidence of intraoperative hypoxemia/desaturation;Incidence of intraoperative hypotension;Total anesthetic drug consumption (propofol, remifentanil, sufentanil, dexmedetomidine);Number of rescue opioid administrations due to cough/movement;Intraoperative blood loss;Anesthesia duration;Block-related complications (hoarseness, Horner’s syndrome, intravascular injection/hematoma);Emergence time;Intraoperative hemodynamic and ventilation stability (MAP, HR, RR, SpO2, PetCO2);Block procedure time;Postoperative length of hospital stay;Time to first ambulation after surgery;Anesthesia preparation time;Intraoperative limb movement grade (1–4);Chest tube placement;

Countries

China

Contacts

Public ContactSu Yongjun

Fuzhou University Affiliated Provincial Hospital

175670378@qq.com+86 591 88618995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026